ST Pharm Co Ltd (237690)

Currency in KRW
99,700
-11,200(-10.10%)
Closed·
Advertisement
Unusual trading volume
237690 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
97,900107,300
52 wk Range
84,100172,100
Key Statistics
Bid/Ask
99,600.00 / 99,700.00
Prev. Close
110,900
Open
105,500
Day's Range
97,900-107,300
52 wk Range
84,100-172,100
Volume
419.83K
Average Volume (3m)
159.1K
1-Year Change
8.3696%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
237690 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
180,000
Upside
+80.54%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 180,000
(+80.54% Upside)

Earnings

Latest Release
14/08/2026
EPS / Forecast
-- / --
Revenue / Forecast
108.5B / 99.41B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3,312.63%
Dividend Yield
0.45%
Industry Median 1.05%
Annualised payout
500.00
Paid annually
5-Years Growth
-
Growth Streak

Compare 237690 to Peers and Sector

Metrics to compare
237690
Peers
Sector
Relationship
P/E Ratio
30.2x8.8x−0.3x
PEG Ratio
0.250.080.00
Price/Book
3.4x0.9x2.6x
Price / LTM Sales
6.0x0.7x3.1x
Upside (Analyst Target)
90.6%56.6%47.6%
Fair Value Upside
Unlock23.0%5.6%Unlock

ST Pharm Co.,Ltd., provides manufacturing services for active pharmaceutical ingredient and intermediate. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical research and development solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.

Employees
655

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.53M7.32%152.39B
Other Institutional Investors
8.88M42.53%885.18B
Public Companies & Retail Investors
10.47M50.15%1.04T
Total
20.88M100.00%2.08T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dong-A Socio Holdings Co., Ltd.29.20%6,096,552607,826,234
The National Pension Fund6.04%1,259,923125,614,323

People Also Watch

32,150
214150
-4.32%
71,600
064400
-2.98%
21,150
012630
-0.70%
18,790
214320
-0.48%
415,500
128940
+4.14%

FAQ

What Is the ST Pharm (KOSDAQ: 237690) Share Price Today?

The ST Pharm stock price today is 99,700 KRW.

What Stock Exchange Does ST Pharm (237690) Trade On?

ST Pharm is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for ST Pharm?

The stock symbol (also called a 'ticker') for ST Pharm is "237690."

Does ST Pharm Pay Dividends? What’s The Current 237690 Dividend Yield?

Yes, 237690 Pays Dividends to its Shareholders. The current ST Pharm dividend yield is 0.45%.

What Is the Current ST Pharm Market Capitalisation?

As of today, ST Pharm (KOSDAQ: 237690) market cap is 2.08T KRW.

What Is ST Pharm's (237690) Earnings Per Share (TTM)?

The ST Pharm EPS is currently 3,313 (Trailing Twelve Months).

When Is the Next ST Pharm Earnings Date?

ST Pharm's next earnings report will be released on 29/10/2026.

Is 237690 a Buy or Sell From a Technical Analyst Perspective?

Based on today's ST Pharm moving averages and other technical indicators, the daily buy/sell signal for 237690 stock is Strong Sell.

How Many Times Has ST Pharm Stock Split?

ST Pharm has split 0 times. (See the 237690 stock split history page for full effective split date and price information.)

How Many Employees Does ST Pharm Have?

ST Pharm has 655 employees, based on their latest Companies House report.

What is the current trading status of ST Pharm (KOSDAQ: 237690)?

As of 22/08/2026, ST Pharm (237690) is trading at a share price of 99,700 KRW, with a previous close of 110,900 KRW. The stock has fluctuated within a day range of 97,900 KRW to 107,300 KRW, while its 52-week range spans from 84,100 KRW to 172,100 KRW.

What Is ST Pharm (237690) Price Target According to Analysts?

The average 12-month price target for ST Pharm is 180,000 KRW, with a high estimate of 210000 KRW and a low estimate of 140000 KRW. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +80.54% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.